[ad_1]
Xia H, Li X, Gao W, Fu X, Fang RH, Zhang L, et al. Tissue restore and regeneration with endogenous stem cells. Nat Rev Mater. 2018;3(7):174–93.
Daar AS, Greenwood HL. A proposed definition of regenerative medication. J Tissue Eng Regen Med. 2007;1(3):179–84.
Jenq RR, Van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune remedy of most cancers. Nat Rev Most cancers. 2010;10(3):213–21.
Chien KR, Frisén J, Fritsche-Danielson R, Melton DA, Murry CE, Weissman IL. Regenerating the sector of cardiovascular cell remedy. Nat Biotechnol. 2019;37(3):232–7.
Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation remedy for spinal twine damage. Nat Neurosci. 2017;20(5):637–47.
Hu X, Leak RK, Thomson AW, Yu F, Xia Y, Wechsler LR, et al. Guarantees and limitations of immune cell-based therapies in neurological problems. Nat Rev Neurol. 2018;14(9):559–68.
Madeira C, Santhagunam A, Salgueiro JB, Cabral JM. Superior cell therapies for articular cartilage regeneration. Tendencies Biotechnol. 2015;33(1):35–42.
Zhou Q, Melton DA. Pancreas regeneration. Nature. 2018;557(7705):351–8.
Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell remedy for superior liver illnesses: restore or rebuild. J Hepatol. 2021;74(1):185–99.
Rani S, Ritter T. The exosome-a naturally secreted nanoparticle and its utility to wound therapeutic. Adv Mater. 2016;28(27):5542–52.
Kimbrel EA, Lanza R. Subsequent-generation stem cells—ushering in a brand new period of cell-based therapies. Nat Rev Drug Discov. 2020;19:1–17.
Hu C-MJ, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013;8(5):336–40.
Fang RH, Hu C-MJ, Luk BT, Gao W, Copp JA, Tai Y, et al. Most cancers cell membrane-coated nanoparticles for anticancer vaccination and drug supply. Nano Lett. 2014;14(4):2181–8.
Clevers H, Watt FM. Defining grownup stem cells by operate, not by phenotype. Annu Rev Biochem. 2018;87:1015–27.
Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in sufferers receiving radiation and chemotherapy. N Engl J Med. 1957;257(11):491–6.
Kabat M, Bobkov I, Kumar S, Grumet M. Tendencies in mesenchymal stem cell medical trials 2004–2018: Is efficacy optimum in a slender dose vary? Stem Cells Transl Med. 2020;9(1):17–27.
Williams LA, Davis-Dusenbery BN, Eggan KC. SnapShot: directed differentiation of pluripotent stem cells. Cell. 2012;149(5):1174.e1.
Kimbrel EA, Lanza R. Present standing of pluripotent stem cells: transferring the primary therapies to the clinic. Nat Rev Drug Discov. 2015;14(10):681–92.
Frantz S. Embryonic stem cell pioneer Geron exits area, cuts losses. Nat Biotechnol. 2012;30(1):12–3.
De Luca M, Aiuti A, Cossu G, Parmar M, Pellegrini G, Robey PG. Advances in stem cell analysis and therapeutic growth. Nat Cell Biol. 2019;21(7):801–11.
Rando TA, Ambrosio F. Regenerative rehabilitation: utilized biophysics meets stem cell therapeutics. Cell Stem Cell. 2018;22(3):306–9.
Galipeau J, Sensébé L. Mesenchymal stromal cells: medical challenges and therapeutic alternatives. Cell Stem Cell. 2018;22(6):824–33.
Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and restore. Nat Rev Cardiol. 2018;15(10):585–600.
Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE, et al. Imaginative and prescient loss after intravitreal injection of autologous “stem cells” for AMD. N Engl J Med. 2017;376(11):1047–53.
Park B-W, Jung S-H, Das S, Lee SM, Park J-H, Kim H, et al. In vivo priming of human mesenchymal stem cells with hepatocyte progress issue–engineered mesenchymal stem cells promotes therapeutic potential for cardiac restore. Sci Adv. 2020;6(13):eaay6994.
García JR, Quirós M, Han WM, O’Leary MN, Cox GN, Nusrat A, et al. IFN-γ-tethered hydrogels improve mesenchymal stem cell-based immunomodulation and promote tissue restore. Biomaterials. 2019;220:119403.
Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, et al. Insertional oncogenesis in 4 sufferers after retrovirus-mediated gene remedy of SCID-X1. J Clin Investig. 2008;118(9):3132–42.
Zufferey R, Boring T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, et al. Self-inactivating lentivirus vector for protected and environment friendly in vivo gene supply. J Virol. 1998;72(12):9873–80.
Jiang F, Doudna JA. CRISPR–Cas9 buildings and mechanisms. Annu Rev Biophys. 2017;46:505–29.
Dai W-J, Zhu L-Y, Yan Z-Y, Xu Y, Wang Q-L, Lu X-J. CRISPR-Cas9 for in vivo gene remedy: promise and hurdles. Mol Ther-Nucl Acids. 2016;5:e349.
Zhang Z, Zhang Y, Gao F, Han S, Cheah KS, Tse H-F, et al. CRISPR/Cas9 genome-editing system in human stem cells: present standing and future prospects. Mol Ther-Nucl Acids. 2017;9:230–41.
Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, et al. Security and efficacy of multipotent grownup progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, part 2 trial. Lancet Neurol. 2017;16(5):360–8.
Moll G, Ankrum JA, Kamhieh-Milz J, Bieback Ok, Ringdén O, Volk H-D, et al. Intravascular mesenchymal stromal/stem cell remedy product diversification: time for brand new medical pointers. Tendencies Mol Med. 2019;25(2):149–63.
Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III. Concise assessment: dissecting a discrepancy within the literature: do mesenchymal stem cells help or suppress tumor progress? Stem Cells. 2011;29(1):11–9.
Oikonomopoulos A, Kitani T, Wu JC. Pluripotent stem cell-derived cardiomyocytes as a platform for cell remedy functions: progress and hurdles for medical translation. Mol Ther. 2018;26(7):1624–34.
Eming SA, Wynn TA, Martin P. Irritation and metabolism in tissue restore and regeneration. Science. 2017;356(6342):1026–30.
Spiller KL, Koh TJ. Macrophage-based therapeutic methods in regenerative medication. Adv Drug Deliv Rev. 2017;122:74–83.
Raffin C, Vo LT, Bluestone JA. T reg cell-based therapies: challenges and views. Nat Rev Immunol. 2020;20(3):158–72.
Honaker Y, Hubbard N, Xiang Y, Fisher L, Hagin D, Sommer Ok, et al. Gene modifying to induce FOXP3 expression in human CD4+T cells results in a secure regulatory phenotype and performance. Sci Transl Med. 2020;12(546):eaay6422.
de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17:1–13.
Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, et al. Making use of extracellular vesicles based mostly therapeutics in medical trials–an ISEV place paper. J Extracell Vesicles. 2015;4(1):30087.
Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparability defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci. 2016;113(8):E968–77.
Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177(2):428-45.e18.
Van Niel G, d’Angelo G, Raposo G. Shedding mild on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213.
Roefs MT, Sluijter JPG, Vader P. Extracellular vesicle-associated proteins in tissue restore. Tendencies Cell Biol. 2020;30(12):990–1013.
Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and different extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17.
Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. Mesenchymal stem cell-derived microvesicles shield in opposition to acute tubular damage. J Am Soc Nephrol. 2009;20(5):1053–67.
Zhang ZG, Buller B, Chopp M. Exosomes—past stem cells for restorative remedy in stroke and neurological damage. Nat Rev Neurol. 2019;15(4):193–203.
Xu T, Luo Y, Wang J, Zhang N, Gu C, Li L, et al. Exosomal miRNA-128-3p from mesenchymal stem cells of aged rats regulates osteogenesis and bone fracture therapeutic by concentrating on Smad5. J Nanobiotechnology. 2020;18(1):47.
Popowski Ok, Lutz H, Hu S, George A, Dinh P-U, Cheng Ok. Exosome therapeutics for lung regenerative medication. J Extracell Vesicles. 2020;9(1):1785161.
Zhang S, Chuah SJ, Lai RC, Hui JHP, Lim SK, Toh WS. MSC exosomes mediate cartilage restore by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16–27.
Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction mannequin. J Mol Med. 2014;92(4):387–97.
Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, et al. Microvesicles derived from mesenchymal stem cells improve survival in a deadly mannequin of acute kidney damage. PLoS ONE. 2012;7(3):e33115.
Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical twine mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845–54.
Solar Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, et al. Human mesenchymal stem cell derived exosomes alleviate kind 2 diabetes mellitus by reversing peripheral insulin resistance and relieving β-cell destruction. ACS Nano. 2018;12(8):7613–28.
Choi JS, Cho WL, Choi YJ, Kim JD, Park H-A, Kim SY, et al. Purposeful restoration in photo-damaged human dermal fibroblasts by human adipose-derived stem cell extracellular vesicles. J Extracell Vesicles. 2019;8(1):1565885.
Dinh P-UC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung restore in pulmonary fibrosis. Nat Commun. 2020;11(1):1–14.
Jiang D, Gong F, Ge X, Lv C, Huang C, Feng S, et al. Neuron-derived exosomes-transmitted miR-124-3p shield traumatically injured spinal twine by suppressing the activation of neurotoxic microglia and astrocytes. J Nanobiotechnology. 2020;18(1):105.
Xiong Y, Chen L, Yan C, Zhou W, Yu T, Solar Y, et al. M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells in the direction of osteoblastic destiny by concentrating on salt-inducible kinase 2 and three. J Nanobiotechnology. 2020;18(1):66.
Lemaire Q, Raffo-Romero A, Arab T, Van Camp C, Drago F, Forte S, et al. Isolation of microglia-derived extracellular vesicles: in the direction of miRNA signatures and neuroprotection. J Nanobiotechnology. 2019;17(1):119.
Kim H, Wang SY, Kwak G, Yang Y, Kwon IC, Kim SH. Exosome-guided phenotypic change of M1 to M2 macrophages for cutaneous wound therapeutic. Adv Sci. 2019;6(20):1900513.
Hu S, Li Z, Lutz H, Huang Ok, Su T, Cores J, et al. Dermal exosomes containing miR-218–5p promote hair regeneration by regulating β-catenin signaling. Sci Adv. 2020;6(30):eaba1685.
Middleton RC, Rogers RG, De Couto G, Tseliou E, Luther Ok, Holewinski R, et al. Newt cells secrete extracellular vesicles with therapeutic bioactivity in mammalian cardiomyocytes. J Extracell Vesicles. 2018;7(1):1456888.
Brennan MÁ, Layrolle P, Mooney DJ. Biomaterials functionalized with MSC secreted extracellular vesicles and soluble elements for tissue regeneration. Adv Funct Mater. 2020;30(37):1909125.
Wiklander OP, Nordin JZ, O’Loughlin A, Gustafsson Y, Corso G, Mäger I, et al. Extracellular vesicle in vivo biodistribution is decided by cell supply, route of administration and concentrating on. J Extracell Vesicles. 2015;4(1):26316.
Lee J-R, Park B-W, Kim J, Choo YW, Kim HY, Yoon J-Ok, et al. Nanovesicles derived from iron oxide nanoparticles–included mesenchymal stem cells for cardiac restore. Sci Adv. 2020;6(18):eaaz0952.
Park DJ, Yun WS, Kim WC, Park JE, Lee SH, Ha S, et al. Enchancment of stem cell-derived exosome launch effectivity by surface-modified nanoparticles. J Nanobiotechnology. 2020;18(1):178.
Bunggulawa EJ, Wang W, Yin T, Wang N, Durkan C, Wang Y, et al. Latest developments in using exosomes as drug supply programs. J Nanobiotechnology. 2018;16(1):81.
Zhang H, Wu J, Wu J, Fan Q, Zhou J, Wu J, et al. Exosome-mediated focused supply of miR-210 for angiogenic remedy after cerebral ischemia in mice. J Nanobiotechnology. 2019;17(1):29.
Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C, et al. Floor functionalized exosomes as focused drug supply autos for cerebral ischemia remedy. Biomaterials. 2018;150:137–49.
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wooden MJ. Supply of siRNA to the mouse mind by systemic injection of focused exosomes. Nat Biotechnol. 2011;29(4):341–5.
Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ, et al. Concentrating on extracellular vesicles to injured tissue utilizing membrane cloaking and floor show. J Nanobiotechnology. 2018;16(1):1–15.
Mentkowski KI, Lang JK. Exosomes engineered to specific a cardiomyocyte binding peptide display improved cardiac retention in vivo. Sci Rep. 2019;9(1):1–13.
Hwang DW, Jo MJ, Lee JH, Kang H, Bao Ok, Hu S, et al. Chemical modulation of bioengineered exosomes for tissue-specific biodistribution. Adv Ther. 2019;2(11):1900111.
Xu X, Liang Y, Li X, Ouyang Ok, Wang M, Cao T, et al. Exosome-mediated supply of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2020;269:120539.
Kim HY, Kumar H, Jo M-J, Kim J, Yoon J-Ok, Lee J-R, et al. Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal twine damage therapy. Nano Lett. 2018;18(8):4965–75.
Fan J, Lee C-S, Kim S, Chen C, Aghaloo T, Lee M. Era of small RNA-modulated exosome mimetics for bone regeneration. ACS Nano. 2020;14(9):11973–84.
Henriques-Antunes H, Cardoso RM, Zonari A, Correia J, Leal EC, Jimenez-Balsa A, et al. The kinetics of small extracellular vesicle supply impacts pores and skin tissue regeneration. ACS Nano. 2019;13(8):8694–707.
Mao Z, Cartier R, Hohl A, Farinacci M, Dorhoi A, Nguyen T-L, et al. Cells as factories for humanized encapsulation. Nano Lett. 2011;11(5):2152–6.
Li R, He Y, Zhu Y, Jiang L, Zhang S, Qin J, et al. Path to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett. 2018;19(1):124–34.
Yang L, Zhai Y, Hao Y, Zhu Z, Cheng G. The regulatory performance of exosomes derived from hUMSCs in 3D tradition for Alzheimer’s illness remedy. Small. 2020;16(3):1906273.
Ran N, Gao X, Dong X, Li J, Lin C, Geng M, et al. Results of exosome-mediated supply of myostatin propeptide on purposeful restoration of mdx mice. Biomaterials. 2020;236:119826.
Su D, Tsai H-I, Xu Z, Yan F, Wu Y, Xiao Y, et al. Exosomal PD-L1 capabilities as an immunosuppressant to advertise wound therapeutic. J Extracell Vesicles. 2020;9(1):1709262.
Jeong D, Jo W, Yoon J, Kim J, Gianchandani S, Gho YS, et al. Nanovesicles engineered from ES cells for enhanced cell proliferation. Biomaterials. 2014;35(34):9302–10.
Tian T, Zhu YL, Hu FH, Wang YY, Huang NP, Xiao ZD. Dynamics of exosome internalization and trafficking. J Cell Physiol. 2013;228(7):1487–95.
Guo X, Wei X, Chen Z, Zhang X, Yang G, Zhou S. Multifunctional nanoplatforms for subcellular supply of medication in most cancers remedy. Prog Mater Sci. 2020;107:100599.
Joshi BS, de Beer MA, Giepmans BN, Zuhorn IS. Endocytosis of extracellular vesicles and launch of their cargo from endosomes. ACS Nano. 2020;14(4):4444–55.
Shin J, Choi S, Kim JH, Cho JH, Jin Y, Kim S, et al. Tissue tapes—phenolic hyaluronic acid hydrogel patches for off-the-shelf remedy. Adv Funct Mater. 2019;29(49):1903863.
Zhu Y, Ma Z, Kong L, He Y, Chan HF, Li H. Modulation of macrophages by bioactive glass/sodium alginate hydrogel is essential in pores and skin regeneration enhancement. Biomaterials. 2020;256:120216.
Zhai M, Zhu Y, Yang M, Mao C. Human mesenchymal stem cell derived exosomes improve cell-free bone regeneration by altering their miRNAs profiles. Adv Sci. 2020;7(19):2001334.
Silva AK, Perretta S, Perrod G, Pidial L, Lindner V, Carn F, et al. Thermoresponsive gel embedded with adipose stem-cell-derived extracellular vesicles promotes esophageal fistula therapeutic in a thermo-actuated supply technique. ACS Nano. 2018;12(10):9800–14.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal info for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 pointers. J Extracell Vesicles. 2018;7(1):1535750.
Zhang X, Zhang H, Gu J, Zhang J, Shi H, Qian H, et al. Engineered extracellular vesicles for most cancers remedy. Adv Mater. 2021;33(14):2005709.
Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic supply platform. Proc Natl Acad Sci. 2011;108(27):10980–5.
Oldenborg P-A, Zheleznyak A, Fang Y-F, Lagenaur CF, Gresham HD, Lindberg FP. Position of CD47 as a marker of self on pink blood cells. Science. 2000;288(5473):2051–4.
Hu C-MJ, Fang RH, Wang Ok-C, Luk BT, Thamphiwatana S, Dehaini D, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–21.
Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Artificial nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like capabilities. Nat Nanotechnol. 2013;8(1):61–8.
Luo L, Tang J, Nishi Ok, Yan C, Dinh P-U, Cores J, et al. Fabrication of artificial mesenchymal stem cells for the therapy of acute myocardial infarction in mice. Circ Res. 2017;120(11):1768–75.
Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8(1):1–9.
Wang S, Jiang R, Meng T, Zhang F, Li J, Jin Y, et al. Stem cell membrane-coated isotretinoin for zits therapy. J Nanobiotechnology. 2020;18(1):106.
Liang H, Huang Ok, Su T, Li Z, Hu S, Dinh P-U, et al. Mesenchymal stem cell/pink blood cell-inspired nanoparticle remedy in mice with carbon tetrachloride-induced acute liver failure. ACS Nano. 2018;12(7):6536–44.
Zhang R, Luo W, Zhang Y, Zhu D, Midgley AC, Tune H, et al. Particle-based synthetic three-dimensional stem cell spheroids for revascularization of ischemic illnesses. Sci Adv. 2020;6(19):eaaz8011.
Yao C, Wu W, Tang H, Jia X, Tang J, Ruan X, et al. Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated restore of myocardial infarction damage. Biomaterials. 2020;257:120256.
Zhang X, Chen J, Jiang Q, Ding X, Li Y, Chen C, et al. Extremely biosafe biomimetic stem cell membrane-disguised nanovehicles for cartilage regeneration. J Mater Chem B. 2020;8(38):8884–93.
Li M, Li J, Chen J, Liu Y, Cheng X, Yang F, et al. Platelet membrane biomimetic magnetic nanocarriers for focused supply and in situ era of nitric oxide in early ischemic stroke. ACS Nano. 2020;14(2):2024–35.
Tao C, Nie X, Zhu W, Iqbal J, Xu C, Wang D-A. Autologous cell membrane coatings on tissue engineering xenografts for suppression and alleviation of acute host immune responses. Biomaterials. 2020;258:120310.
Ma J, Zhang S, Liu J, Liu F, Du F, Li M, et al. Focused drug supply to stroke by way of chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells. Small. 2019;15(35):1902011.
Xu J, Wang X, Yin H, Cao X, Hu Q, Lv W, et al. Sequentially site-specific supply of thrombolytics and neuroprotectant for enhanced therapy of ischemic stroke. ACS Nano. 2019;13(8):8577–88.
Wang Y, Zhang Ok, Qin X, Li T, Qiu J, Yin T, et al. Biomimetic nanotherapies: pink blood cell based mostly core–shell structured nanocomplexes for atherosclerosis administration. Adv Sci. 2019;6(12):1900172.
Tune Y, Huang Z, Liu X, Pang Z, Chen J, Yang H, et al. Platelet membrane-coated nanoparticle-mediated concentrating on supply of Rapamycin blocks atherosclerotic plaque growth and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice. Nanomed Nanotechnol Biol Med. 2019;15(1):13–24.
Wang S, Wang R, Meng N, Guo H, Wu S, Wang X, et al. Platelet membrane-functionalized nanoparticles with improved concentrating on skill and decrease hemorrhagic threat for thrombolysis remedy. J Management Launch. 2020;328:78–86.
Yang H, Tune Y, Chen J, Pang Z, Zhang N, Cao J, et al. Platelet membrane-coated nanoparticles goal sclerotic aortic valves in ApoE−/− mice by a number of binding mechanisms below pathological shear stress. Int J Nanomed. 2020;15:901.
Li M, Liu Y, Chen J, Liu T, Gu Z, Zhang J, et al. Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics. Theranostics. 2018;8(18):4870.
Zhang Q, Dehaini D, Zhang Y, Zhou J, Chen X, Zhang L, et al. Neutrophil membrane-coated nanoparticles inhibit synovial irritation and alleviate joint injury in inflammatory arthritis. Nat Nanotechnol. 2018;13(12):1182–90.
Zhou X, Cao X, Tu H, Zhang Z-R, Deng L. Irritation-targeted supply of Celastrol by way of neutrophil membrane-coated nanoparticles within the administration of acute pancreatitis. Mol Pharm. 2019;16(3):1397–405.
Liu Z, Liu X, Yang Q, Yu L, Chang Y, Qu M. Neutrophil membrane-enveloped nanoparticles for the amelioration of renal ischemia-reperfusion damage in mice. Acta Biomater. 2020;104:158–66.
Wang Y, Zhang Ok, Li T, Maruf A, Qin X, Luo L, et al. Macrophage membrane functionalized biomimetic nanoparticles for focused anti-atherosclerosis functions. Theranostics. 2021;11(1):164.
Zhuang J, Duan Y, Zhang Q, Gao W, Li S, Fang RH, et al. Multimodal enzyme supply and remedy enabled by cell membrane-coated metal-organic framework nanoparticles. Nano Lett. 2020;20(5):4051–8.
Liu H, Han Y, Wang T, Zhang H, Xu Q, Yuan J, et al. Concentrating on microglia for remedy of Parkinson’s illness by utilizing biomimetic ultrasmall nanoparticles. J Am Chem Soc. 2020;142(52):21730–42.
He W, Mei Q, Li J, Zhai Y, Chen Y, Wang R, et al. Preferential concentrating on cerebral ischemic lesions with most cancers cell-inspired nanovehicle for ischemic stroke therapy. Nano Lett. 2021;21(7):3033–43.
Gao C, Huang Q, Liu C, Kwong CH, Yue L, Wan J-B, et al. Remedy of atherosclerosis by macrophage-biomimetic nanoparticles by way of focused pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun. 2020;11(1):1–14.
Solar T, Kwong CH, Gao C, Wei J, Yue L, Zhang J, et al. Amelioration of ulcerative colitis by way of inflammatory regulation by macrophage-biomimetic nanomedicine. Theranostics. 2020;10(22):10106.
Lv W, Xu J, Wang X, Li X, Xu Q, Xin H. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke therapy. ACS Nano. 2018;12(6):5417–26.
Du Z, Liu C, Tune H, Scott P, Liu Z, Ren J, et al. Neutrophil-membrane-directed bioorthogonal synthesis of inflammation-targeting chiral medication. Chem. 2020;6(8):2060–72.
Fan Z, Li PY, Deng J, Bady SC, Cheng H. Cell membrane coating for decreasing nanoparticle-induced inflammatory responses to scaffold constructs. Nano Res. 2018;11(10):5573–83.
Hu C, Luo R, Wang Y. Coronary heart valves cross-linked with erythrocyte membrane drug-loaded nanoparticles as a biomimetic technique for anti-coagulation, anti-inflammation, anti-calcification, and endothelialization. ACS Appl Mater Interfaces. 2020;12(37):41113–26.
Chen W, Zhang Q, Luk BT, Fang RH, Liu Y, Gao W, et al. Coating nanofiber scaffolds with beta cell membrane to advertise cell proliferation and performance. Nanoscale. 2016;8(19):10364–70.
Nishiguchi A, Taguchi T. Improvement of an immunosuppressive camouflage-coating platform with nanocellulose and cell membrane vesicles. J Biomater Sci Polym Ed. 2020;31(15):1912–24.
Fan Z, Deng J, Li PY, Chery DR, Su Y, Zhu P, et al. A brand new class of organic supplies: cell membrane-derived hydrogel scaffolds. Biomaterials. 2019;197:244–54.
Yin C, Zhao Q, Li W, Zhao Z, Wang J, Deng T, et al. Biomimetic anti-inflammatory nano-capsule serves as a cytokine blocker and M2 polarization inducer for bone tissue restore. Acta Biomater. 2020;102:416–26.
Abbina S, Siren EM, Moon H, Kizhakkedathu JN. Floor engineering for cell-based therapies: Methods for manipulating mammalian cell surfaces. ACS Biomater Sci Eng. 2017;4(11):3658–77.
Bose RJ, Kim BJ, Arai Y, Han I-B, Moon JJ, Paulmurugan R, et al. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic concentrating on of extreme hindlimb ischemia. Biomaterials. 2018;185:360–70.
Xue Y, Zeng G, Cheng J, Hu J, Zhang M, Li Y. Engineered macrophage membrane-enveloped nanomedicine for ameliorating myocardial infarction in a mouse mannequin. Bioeng Transl Med. 2020;6(2):e10197.
Ou Z, Zhong H, Zhang L, Deng M, Zhang W, Wang J, et al. Macrophage membrane-coated nanoparticles alleviate hepatic ischemia-reperfusion damage brought on by orthotopic liver transplantation by neutralizing endotoxin. Int J Nanomed. 2020;15:4125–38.
Shi Y, Xie F, Rao P, Qian H, Chen R, Chen H, et al. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis remedy. J Management Launch. 2020;320:304–13.
Yan H, Shao D, Lao YH, Li M, Hu H, Leong KW. Engineering cell membrane-based nanotherapeutics to focus on irritation. Adv Sci. 2019;6(15):1900605.
Su T, Huang Ok, Ma H, Liang H, Dinh PU, Chen J, et al. Platelet-inspired nanocells for focused coronary heart restore after ischemia/reperfusion damage. Adv Func Mater. 2019;29(4):1803567.
Han Y, Gao C, Wang H, Solar J, Liang M, Feng Y, et al. Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP enhance mind neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer’s illness mice. Bioact Mater. 2021;6(2):529–42.
Han Y, Chu X, Cui L, Fu S, Gao C, Li Y, et al. Neuronal mitochondria-targeted remedy for Alzheimer’s illness by systemic supply of resveratrol utilizing dual-modified novel biomimetic nanosystems. Drug Supply. 2020;27(1):502–18.
Wu G, Wei W, Zhang J, Nie W, Yuan L, Huang Y, et al. A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and therapy of atherosclerosis. Biomaterials. 2020;250:119963.
Xu J, Zhang Y, Xu J, Liu G, Di C, Zhao X, et al. Engineered nanoplatelets for focused supply of plasminogen activators to reverse thrombus in a number of mouse thrombosis fashions. Adv Mater. 2020;32(4):1905145.
Zhao Y, Xie R, Yodsanit N, Ye M, Wang Y, Gong S. Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus remedy. Nano At this time. 2020;35:100986.
Kraynak CA, Yan DJ, Suggs LJ. Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle. Acta Biomater. 2020;108:250–60.
Dou G, Tian R, Liu X, Yuan P, Ye Q, Liu J, et al. Chimeric apoptotic our bodies functionalized with pure membrane and modular supply system for irritation modulation. Sci Adv. 2020;6(30):2987.
Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil membrane-derived nanovesicles alleviate irritation to guard mouse mind damage from ischemic stroke. ACS Nano. 2019;13(2):1272–83.
Wu H, Jiang X, Li Y, Zhou Y, Zhang T, Zhi P, et al. Engineering stem cell derived biomimetic vesicles for versatility and efficient focused supply. Adv Func Mater. 2020;30(49):2006169.
Tune Y, Zhang N, Li Q, Chen J, Wang Q, Yang H, et al. Biomimetic liposomes hybrid with platelet membranes for focused remedy of atherosclerosis. Chem Eng J. 2020;408:127296.
Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, et al. Biomimetic proteolipid vesicles for concentrating on infected tissues. Nat Mater. 2016;15(9):1037–46.
Zhang N, Tune Y, Huang Z, Chen J, Tan H, Yang H, et al. Monocyte mimics enhance mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI mannequin. Biomaterials. 2020;255:120168.
Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30(23):1706759.
Corbo C, Cromer WE, Molinaro R, Furman NET, Hartman KA, De Rosa E, et al. Engineered biomimetic nanovesicles present intrinsic anti-inflammatory properties for the therapy of inflammatory bowel illnesses. Nanoscale. 2017;9(38):14581–91.
Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman Ok, et al. Rapamycin-loaded biomimetic nanoparticles reverse vascular irritation. Circ Res. 2020;126(1):25–37.
Zinger A, Sushnitha M, Naoi T, Baudo G, De Rosa E, Chang J, et al. Enhancing irritation concentrating on utilizing tunable leukocyte-based biomimetic nanoparticles. ACS Nano. 2021;15(4):6326–39.
Tang J, Su T, Huang Ok, Dinh P-U, Wang Z, Vandergriff A, et al. Focused restore of coronary heart damage by stem cells fused with platelet nanovesicles. Nat Biomed Eng. 2018;2(1):17–26.
Li Y, Teng X, Yang C, Wang Y, Wang L, Dai Y, et al. Ultrasound managed anti-inflammatory polarization of platelet adorned microglia for focused ischemic stroke remedy. Angew Chem Int Ed Engl. 2021;60(10):5083–90.
Lee J-R, Kyung JW, Kumar H, Kwon SP, Tune SY, Han I-B, et al. Focused supply of mesenchymal stem cell-derived nanovesicles for spinal twine damage therapy. Int J Mol Sci. 2020;21(11):4185.
Herrmann IK, Wooden MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug supply platform. Nat Nanotechnol. 2021;16(7):748–59.
Kordelas L, Rebmann V, Ludwig A, Radtke S, Ruesing J, Doeppner T, et al. MSC-derived exosomes: a novel instrument to deal with therapy-refractory graft-versus-host illness. Leukemia. 2014;28(4):970–3.
Ng KS, Smith JA, McAteer MP, Mead BE, Ware J, Jackson FO, et al. Bioprocess choice help instrument for scalable manufacture of extracellular vesicles. Biotechnol Bioeng. 2019;116(2):307–19.
Kang M, Hong J, Jung M, Kwon SP, Tune SY, Kim HY, et al. T-cell-mimicking nanoparticles for most cancers immunotherapy. Adv Mater. 2020;32(39):2003368.
Moreau T, Evans AL, Vasquez L, Tijssen MR, Yan Y, Trotter MW, et al. Giant-scale manufacturing of megakaryocytes from human pluripotent stem cells by chemically outlined ahead programming. Nat Commun. 2016;7:11208.
Setyawati MI, Tay CY, Chia SL, Goh SL, Fang W, Neo MJ, et al. Titanium dioxide nanomaterials trigger endothelial cell leakiness by disrupting the homophilic interplay of VE–cadherin. Nat Commun. 2013;4(1):1673.
Tee JK, Yip LX, Tan ES, Santitewagun S, Prasath A, Ke PC, et al. Nanoparticles’ interactions with vasculature in illnesses. Chem Soc Rev. 2019;48(21):5381–407.
Nourshargh S, Alon R. Leukocyte migration into infected tissues. Immunity. 2014;41(5):694–707.
Hayashi Ok, Yamada S, Hayashi H, Sakamoto W, Yogo T. Crimson blood cell-like particles with the power to keep away from lung and spleen accumulation for the therapy of liver fibrosis. Biomaterials. 2018;156:45–55.
Gong H, Zhang Q, Komarla A, Wang S, Duan Y, Zhou Z, et al. Nanomaterial biointerfacing by way of mitochondrial membrane coating for focused cleansing and molecular detection. Nano Lett. 2021;21(6):2603–9.
Vringer E, Tait SWG. Mitochondria and irritation: cell demise heats up. Entrance Cell Dev Biol. 2019;7:100.
Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, et al. Rising position of damage-associated molecular patterns derived from mitochondria in irritation. Tendencies Immunol. 2011;32(4):157–64.
Mukwaya V, Zhang P, Liu L, Dang-i AY, Li M, Mann S, et al. Programmable membrane-mediated attachment of artificial virus-like nanoparticles on synthetic protocells for enhanced immunogenicity. Cell Rep Phys Sci. 2021;2(1):100291.
Matosevic S, Paegel BM. Layer-by-layer cell membrane meeting. Nat Chem. 2013;5(11):958–63.
Thamboo S, Najer A, Belluati A, von Planta C, Wu D, Craciun I, et al. Mimicking mobile signaling pathways inside artificial multicompartment vesicles with triggered enzyme exercise and induced ion channel recruitment. Adv Func Mater. 2019;29(40):1904267.
Weiss M, Frohnmayer JP, Benk LT, Haller B, Janiesch JW, Heitkamp T, et al. Sequential bottom-up meeting of mechanically stabilized artificial cells by microfluidics. Nat Mater. 2018;17(1):89–96.
Chen Z, Wang J, Solar W, Archibong E, Kahkoska AR, Zhang X, et al. Artificial beta cells for fusion-mediated dynamic insulin secretion. Nat Chem Biol. 2018;14(1):86.
[ad_2]
